L 3 0 , C o l l i n s P l a c e , 3 5 C o l l i n s S t r e e t , M e l b o u r n e , V I C 3 0 0 0 , A u s t r a l i aE:i n f o @ P e r c h e r o n T x . c o m ¦ T:+ 6 1 3 9 8 2 7 8 9 9 9www.PercheronTx.com 15 October 2026 ASX Market Announcements O?ice ASX Limited Level 4, North...
Notice under S708A
Filed with ASX ·
6ix hasn’t read this filing yet.
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Application for quotation of securities - PER
- Change of Director's Interest Notice
- Notification regarding unquoted securities - PER
- Results of Annual General Meeting
- Annual General Meeting - Management Presentation
Later from Percheron Therapeutics
- PER: Percheron and Invion Explore Cancer Combination Therapy
- Photosoft & Novel Immunotherapy Collab Partnership
- Quarterly Activities Report and Appendix 4C
- Completion of HMBD-002 Drug Product Manufacture
- Listing Rule waiver to allow quotation of PERAQ options
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics